Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Maribavir in Adults and Children With Post-transplant Cytomegalovirus (CMV) Infection in Argentina
Sponsor: Takeda
Summary
The main aim of this study is to learn about the safety of Maribavir in adults and children with post-transplant CMV infection in routine clinical practice in Argentina. The other aim is to study the effectiveness of the treatment with Maribavir in routine clinical practice in Argentina. Participants will be treated by their doctors according to normal medical practice. Study data will be collected either from information already available in the medical records or during study conduct.
Official title: Post Authorization Study to Monitor Efficacy, Effectiveness, and Safety of Maribavir (LIVTENCITY®) in Patients With Post-transplant Cytomegalovirus (CMV) Infection in Argentina
Key Details
Gender
All
Age Range
12 Years - Any
Study Type
OBSERVATIONAL
Enrollment
10
Start Date
2024-09-03
Completion Date
2026-09-01
Last Updated
2025-07-09
Healthy Volunteers
No
Conditions
Interventions
No Intervention
This is non-interventional study.
Locations (1)
IC Projects
City of Buenos Aires, Argentina